Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Friday, November 9, 2012

Research and Markets: Global Acute Ischemic Stroke Epidemiology and Patient Flow Analysis - 2012

If you want to be an entrepreneur in the stroke market this might be useful.
http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=66824#.UJ04jNcvnAw
Fore Pharma announced the results of its Acute Ischemic Stroke patient population study in a new report Global Acute Ischemic Stroke Epidemiology and Patient Flow Analysis - 2012'. The report provides insights into Acute Ischemic Stroke epidemiology, Acute Ischemic Stroke diagnosed patients, and Acute Ischemic Stroke treatment rate for top seven pharmaceutical markets. The study measures key indicators such as prevalence of Acute Ischemic Stroke derived from epidemiological analysis, percentage of patients diagnosed with Acute Ischemic Stroke, and percentage of patients treated with Acute Ischemic Stroke therapy.
This study helps executives estimate Acute Ischemic Stroke market potential, assess unmet need, develop drug forecasting models, and build population-based health management frameworks. The information presented in this study is used to evaluate market opportunities, effectively identify target patient population, and align marketing decisions.
This report provides estimates and forecasts of Acute Ischemic Stroke prevalence, Acute Ischemic Stroke diagnosis rate, and Acute Ischemic Stroke treatment rate for the period 2012-2019. The information is presented by leading geographies including the US, Germany, France, Spain, Italy, UK, and Japan. The study design is based on collection and interpretation of data from registries, scientific journals and literatures, government databases and other secondary sources.
Key Features of the Report:
- Acute Ischemic Stroke: Disease Definition
- Acute Ischemic Stroke Patient Flow
- Acute Ischemic Stroke Prevalence
- Acute Ischemic Stroke Diagnosed Patients
- Acute Ischemic Stroke Treated Patients

Posted by at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)